136 related articles for article (PubMed ID: 33971157)
21. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin.
Nachat R; Méchin MC; Takahara H; Chavanas S; Charveron M; Serre G; Simon M
J Invest Dermatol; 2005 Feb; 124(2):384-93. PubMed ID: 15675958
[TBL] [Abstract][Full Text] [Related]
22. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
23. Phytoalexin-deficient mutants of Arabidopsis reveal that PAD4 encodes a regulatory factor and that four PAD genes contribute to downy mildew resistance.
Glazebrook J; Zook M; Mert F; Kagan I; Rogers EE; Crute IR; Holub EB; Hammerschmidt R; Ausubel FM
Genetics; 1997 May; 146(1):381-92. PubMed ID: 9136026
[TBL] [Abstract][Full Text] [Related]
24. Deimination in epidermal barrier and hair formation.
Méchin MC; Simon M
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220245. PubMed ID: 37778378
[TBL] [Abstract][Full Text] [Related]
25. The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations.
Méchin MC; Enji M; Nachat R; Chavanas S; Charveron M; Ishida-Yamamoto A; Serre G; Takahara H; Simon M
Cell Mol Life Sci; 2005 Sep; 62(17):1984-95. PubMed ID: 16091842
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
Jones JE; Slack JL; Fang P; Zhang X; Subramanian V; Causey CP; Coonrod SA; Guo M; Thompson PR
ACS Chem Biol; 2012 Jan; 7(1):160-5. PubMed ID: 22004374
[TBL] [Abstract][Full Text] [Related]
27. Peptidylarginine deiminase isoforms are differentially expressed in the anagen hair follicles and other human skin appendages.
Nachat R; Méchin MC; Charveron M; Serre G; Constans J; Simon M
J Invest Dermatol; 2005 Jul; 125(1):34-41. PubMed ID: 15982300
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?
Padhy DS; Palit P; Ikbal AMA; Das N; Roy DK; Banerjee S
Inflammopharmacology; 2023 Apr; 31(2):731-744. PubMed ID: 36806957
[TBL] [Abstract][Full Text] [Related]
29. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
30. Peptidylarginine deiminase is involved in maintaining the cornified oral mucosa of rats.
Arita S; Hatta M; Uchida K; Kita T; Okamura K; Ryu T; Murakami H; Sakagami R; Yamazaki J
J Periodontal Res; 2018 Oct; 53(5):750-761. PubMed ID: 29687476
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4.
Arita K; Shimizu T; Hashimoto H; Hidaka Y; Yamada M; Sato M
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5291-6. PubMed ID: 16567635
[TBL] [Abstract][Full Text] [Related]
32. Induction of peptidylarginine deiminase 2 and 3 by dibutyryl cAMP via cAMP-PKA signaling in human astrocytoma U-251MG cells.
Masutomi H; Kawashima S; Kondo Y; Uchida Y; Jang B; Choi EK; Kim YS; Shimokado K; Ishigami A
J Neurosci Res; 2017 Jul; 95(7):1503-1512. PubMed ID: 27704563
[TBL] [Abstract][Full Text] [Related]
33. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
[TBL] [Abstract][Full Text] [Related]
34. Evolution of S100A3 and PAD3, two important genes for mammalian hair.
Minato T; Unno M; Kitano T
Gene; 2019 Sep; 713():143975. PubMed ID: 31302167
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of peptidylarginine deiminase type 1 in reconstructed human epidermis disturbs nucleophagy in the granular layer and affects barrier function.
Alioli AC; Briot J; Pons C; Yang H; Gairin M; Goudounèche D; Cau L; Simon M; Méchin MC
Cell Death Discov; 2023 Jun; 9(1):198. PubMed ID: 37385992
[TBL] [Abstract][Full Text] [Related]
36. Microglial expression of peptidylarginine deiminase 2 in the prenatal rat brain.
Asaga H; Ishigami A
Cell Mol Biol Lett; 2007; 12(4):536-44. PubMed ID: 17579814
[TBL] [Abstract][Full Text] [Related]
37. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.
Kosgodage US; Uysal-Onganer P; MacLatchy A; Kraev I; Chatterton NP; Nicholas AP; Inal JM; Lange S
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597867
[TBL] [Abstract][Full Text] [Related]
38. Acefylline activates filaggrin deimination by peptidylarginine deiminases in the upper epidermis.
Méchin MC; Cau L; Galliano MF; Daunes-Marion S; Poigny S; Vidaluc JL; Bessou-Touya S; Takahara H; Serre G; Duplan H; Simon M
J Dermatol Sci; 2016 Feb; 81(2):101-6. PubMed ID: 26616205
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
Front Immunol; 2018; 9():2696. PubMed ID: 30515171
[No Abstract] [Full Text] [Related]
40. Structural basis for Ca(2+)-induced activation of human PAD4.
Arita K; Hashimoto H; Shimizu T; Nakashima K; Yamada M; Sato M
Nat Struct Mol Biol; 2004 Aug; 11(8):777-83. PubMed ID: 15247907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
